Goldman Sachs’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $779K | Sell |
137,146
-63,304
| -32% | -$360K | ﹤0.01% | 3993 |
|
|
2025
Q1 | $954K | Buy |
200,450
+66,422
| +50% | +$316K | ﹤0.01% | 3831 |
|
|
2024
Q4 | $747K | Buy |
+134,028
| New | +$747K | ﹤0.01% | 4090 |
|
|
2024
Q2 | – | Sell |
-171,533
| Closed | -$1.24M | – | 4719 |
|
|
2024
Q1 | $1.24M | Buy |
+171,533
| New | +$1.24M | ﹤0.01% | 3489 |
|
|
2023
Q3 | – | Sell |
-213,282
| Closed | -$860K | – | 4717 |
|
|
2023
Q2 | $860K | Buy |
213,282
+50,008
| +31% | +$202K | ﹤0.01% | 3712 |
|
|
2023
Q1 | $460K | Sell |
163,274
-6,387
| -4% | -$18K | ﹤0.01% | 4109 |
|
|
2022
Q4 | $523K | Buy |
+169,661
| New | +$523K | ﹤0.01% | 4067 |
|
|
2021
Q4 | – | Sell |
-4,528
| Closed | -$127K | – | 5521 |
|
|
2021
Q3 | $127K | Sell |
4,528
-8,654
| -66% | -$243K | ﹤0.01% | 5008 |
|
|
2021
Q2 | $515K | Buy |
13,182
+7,808
| +145% | +$305K | ﹤0.01% | 4411 |
|
|
2021
Q1 | $252K | Buy |
5,374
+3,412
| +174% | +$160K | ﹤0.01% | 4717 |
|
|
2020
Q4 | $77K | Sell |
1,962
-7,413
| -79% | -$291K | ﹤0.01% | 4507 |
|
|
2020
Q3 | $239K | Buy |
9,375
+423
| +5% | +$10.8K | ﹤0.01% | 4002 |
|
|
2020
Q2 | $652K | Sell |
8,952
-3,416
| -28% | -$249K | ﹤0.01% | 3463 |
|
|
2020
Q1 | $649K | Buy |
12,368
+1,225
| +11% | +$64.3K | ﹤0.01% | 3352 |
|
|
2019
Q4 | $911K | Buy |
11,143
+1,296
| +13% | +$106K | ﹤0.01% | 3379 |
|
|
2019
Q3 | $556K | Buy |
9,847
+6,756
| +219% | +$381K | ﹤0.01% | 3546 |
|
|
2019
Q2 | $369K | Buy |
3,091
+963
| +45% | +$115K | ﹤0.01% | 3632 |
|
|
2019
Q1 | $392K | Buy |
2,128
+428
| +25% | +$78.8K | ﹤0.01% | 3655 |
|
|
2018
Q4 | $304K | Sell |
1,700
-462
| -21% | -$82.6K | ﹤0.01% | 3600 |
|
|
2018
Q3 | $692K | Buy |
2,162
+1,512
| +233% | +$484K | ﹤0.01% | 3329 |
|
|
2018
Q2 | $260K | Sell |
650
-1,620
| -71% | -$648K | ﹤0.01% | 3779 |
|
|
2018
Q1 | $815K | Sell |
2,270
-1,198
| -35% | -$430K | ﹤0.01% | 3276 |
|
|
2017
Q4 | $1.37M | Sell |
3,468
-2,277
| -40% | -$902K | ﹤0.01% | 3016 |
|
|
2017
Q3 | $2.45M | Buy |
5,745
+5,321
| +1,255% | +$2.27M | ﹤0.01% | 2762 |
|
|
2017
Q2 | $68K | Sell |
424
-4,216
| -91% | -$676K | ﹤0.01% | 4212 |
|
|
2017
Q1 | $580K | Buy |
4,640
+4,162
| +871% | +$520K | ﹤0.01% | 3417 |
|
|
2016
Q4 | $58K | Sell |
478
-2,260
| -83% | -$274K | ﹤0.01% | 4214 |
|
|
2016
Q3 | $411K | Buy |
2,738
+2,036
| +290% | +$306K | ﹤0.01% | 3539 |
|
|
2016
Q2 | $41K | Buy |
702
+217
| +45% | +$12.7K | ﹤0.01% | 4296 |
|
|
2016
Q1 | $31K | Sell |
485
-404
| -45% | -$25.8K | ﹤0.01% | 4308 |
|
|
2015
Q4 | $75K | Buy |
+889
| New | +$75K | ﹤0.01% | 4063 |
|